Buckley Kohlhauff
Hoofd Techniek/Wetenschap/O&O bij NURIX THERAPEUTICS, INC.
Actieve functies van Buckley Kohlhauff
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NURIX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2021 | - |
Loopbaan van Buckley Kohlhauff
Eerdere bekende functies van Buckley Kohlhauff
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LEXICON PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
FIVE PRIME THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Buckley Kohlhauff
Carnegie Mellon University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NURIX THERAPEUTICS, INC. | Health Technology |
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
- Beurs
- Insiders
- Buckley Kohlhauff
- Ervaring